KROGER PARTNERING WITH THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) TO HELP KIDS WITH BLOOD CANCER

Rhea-AI Summary

Kroger (KR) has partnered with The Leukemia & Lymphoma Society (LLS) for a fundraising campaign in North Texas and Louisiana to support The Dare to Dream Project. The initiative runs from May 14 to June 3, 2025 across 110 Kroger stores, allowing customers to donate at checkout. The project aims to develop safer, less toxic treatments for pediatric blood cancer patients and provide free support resources for families.

Currently, only 5% of cancer drugs are approved for first-time use in children, and 80% of childhood cancer survivors develop chronic health issues from treatment. LLS has launched significant initiatives including the first pediatric AML Data Commons platform and the LLS PedAL Master Clinical Trial, which matches patients to treatments based on their cancer's unique tumor biology.

News Market Reaction

-1.70%

1 alert

-1.70% News Effect

On the day this news was published, KR declined 1.70%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Funds Raised in North Texas and Louisiana to Benefit the Work of LLS's The Dare to Dream Project to Bring Safer, Less Toxic Treatments for Kids with Blood Cancer & Provide Free Support & Resources for Their Families

DALLAS, May 14, 2025 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) has partnered with Kroger's Dallas Division to raise funds in North Texas and Louisiana in support of The Dare to Dream Project. LLS is working to transform treatment and care for pediatric blood cancer patients and funds raised at participating Kroger locations will exclusively benefit the life-saving work of The Dare to Dream Project and will help LLS achieve its goal to ensure kids receive the blood cancer treatments live longer, better lives.

From May 14, 2025 – June 3, 2025, Kroger encourages shoppers to help us support LLS's Dare to Dream Project by donating at checkout in-store at one of its 110 stores in North and East Texas and Louisiana.

Each donation/sale will support cutting-edge research and help improve the lives of children and families affected by blood cancer.

Supporting LLS and The Dare to Dream Project

Through The Dare to Dream Project, LLS has responded to the urgent need for safer, less toxic treatments and access to free support and resources for pediatric blood cancer patients and their families. Kids are different and deserve kid-sized treatments. Yet only 5% of cancer drugs have been approved for first-time use in kids, and 80% of childhood cancer survivors develop chronic health issues from their treatment.

"LLS is so grateful to be partnering with Kroger's Dallas Division on this critical effort to transform treatment and care for kids with blood cancer," says LLS Dare to Dream Project Vice President Jim Brewer. "We've already accomplished so much through The Dare to Dream Project, but much more work needs to be done for our youngest patients and their families. The generous support of Kroger's Dallas Division will make a huge impact on this initiative." 

LLS is pioneering pediatric blood cancer research – funding the first-ever pediatric AML Data Commons, a platform that ensures consistency in global data reporting, and has launched the first-ever acute leukemia LLS PedAL Master Clinical Trial, which matches patients to treatment based on their cancer's unique tumor biology.

ABOUT KROGER'S DALLAS DIVISION
At Kroger, a company of The Kroger Co. (NYSE: KR), we are Fresh for Everyone™ and dedicated to our Purpose: To Feed the Human Spirit®. We are 13,000 associates in 110 stores who serve customers daily through a seamless shopping experience throughout North Texas to West Louisiana. We are committed to creating #ZeroHungerZeroWaste communities by 2025. To learn more about us, visit our newsroom and investor relations site.

ABOUT THE LEUKEMIA & LYMPHOMA SOCIETY
The Leukemia & Lymphoma Society® (LLS) is the global leader and innovator in creating a world without blood cancer. The LLS mission: Cure blood cancer and improve the quality of life of all patients and their families. LLS is focused on accelerating research, providing free support and services, and advocating for policies to ensure access to quality, affordable care. For more than 75 years, LLS has been helping blood cancer patients live longer, better lives.

To learn more, visit www.LLS.org. Patients can contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET. Connect with us on Facebook, X, Instagram, LinkedIn and TikTok. 

ABOUT THE DARE TO DREAM PROJECT
The Dare to Dream Project is a bold and urgent $175 million campaign that is funding and accelerating groundbreaking, global, collaborative pediatric blood cancer research; driving advocacy and pediatric healthcare policy changes; and expanding our wide variety of free education, resources, and support services for kids with blood cancer and their families.

Since its launch, The Leukemia & Lymphoma Society has been transforming treatment and care for kids with blood cancer, making much needed progress.

Learn more at https://www.lls.org/dare-to-dream.

Media Contact: Melissa Valentino mediarelations@lls.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/kroger-partnering-with-the-leukemia--lymphoma-society-lls-to-help-kids-with-blood-cancer-302454652.html

SOURCE The Leukemia & Lymphoma Society (LLS)

FAQ

What is Kroger's partnership with The Leukemia & Lymphoma Society in 2025?

Kroger is partnering with LLS from May 14-June 3, 2025, for a fundraising campaign across 110 stores in North Texas and Louisiana to support The Dare to Dream Project, which focuses on developing safer treatments for pediatric blood cancer patients.

How many Kroger stores are participating in the LLS fundraising campaign?

110 Kroger stores across North and East Texas and Louisiana are participating in the fundraising campaign.

What is the Dare to Dream Project's main objective?

The Dare to Dream Project aims to develop safer, less toxic treatments for pediatric blood cancer patients and provide free support and resources for their families.

What initiatives has LLS launched through the Dare to Dream Project?

LLS has launched the first pediatric AML Data Commons platform for consistent global data reporting and the LLS PedAL Master Clinical Trial, which matches patients to treatments based on their cancer's tumor biology.